These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 38412598
1. Recurrent C3 glomerulopathy after kidney transplantation. Obata S, Vaz de Castro PAS, Riella LV, Cravedi P. Transplant Rev (Orlando); 2024 Apr; 38(2):100839. PubMed ID: 38412598 [Abstract] [Full Text] [Related]
2. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents. Holle J, Berenberg-Goßler L, Wu K, Beringer O, Kropp F, Müller D, Thumfart J. Pediatr Nephrol; 2018 Dec; 33(12):2289-2298. PubMed ID: 30238151 [Abstract] [Full Text] [Related]
3. Kidney transplantation in children and adolescents with C3 glomerulopathy or immune complex membranoproliferative glomerulonephritis: a real-world study within the CERTAIN research network. Patry C, Webb NJA, Feißt M, Krupka K, Becker J, Bald M, Antoniello B, Bilge I, Gulhan B, Hogan J, Kanzelmeyer N, Ozkaya O, Büscher A, Sellier-Leclerc AL, Shenoy M, Weber LT, Fichtner A, Höcker B, Meier M, Tönshoff B. Pediatr Nephrol; 2024 Dec; 39(12):3569-3580. PubMed ID: 39110227 [Abstract] [Full Text] [Related]
4. C3 glomerulopathy: Understanding an ultra-rare complement-mediated renal disease. Heiderscheit AK, Hauer JJ, Smith RJH. Am J Med Genet C Semin Med Genet; 2022 Sep; 190(3):344-357. PubMed ID: 35734939 [Abstract] [Full Text] [Related]
5. Kidney Transplantation in C3 Glomerulopathy: A Case Series. Regunathan-Shenk R, Avasare RS, Ahn W, Canetta PA, Cohen DJ, Appel GB, Bomback AS. Am J Kidney Dis; 2019 Mar; 73(3):316-323. PubMed ID: 30413277 [Abstract] [Full Text] [Related]
7. C3 glomerulopathy and current dilemmas. Ito N, Ohashi R, Nagata M. Clin Exp Nephrol; 2017 Aug; 21(4):541-551. PubMed ID: 27878657 [Abstract] [Full Text] [Related]
8. C3 glomerulopathy and eculizumab: a report on four paediatric cases. Lebreton C, Bacchetta J, Dijoud F, Bessenay L, Fremeaux-Bacchi V, Sellier-Leclerc AL. Pediatr Nephrol; 2017 Jun; 32(6):1023-1028. PubMed ID: 28236143 [Abstract] [Full Text] [Related]
9. C4 Nephritic Factors in C3 Glomerulopathy: A Case Series. Zhang Y, Meyer NC, Fervenza FC, Lau W, Keenan A, Cara-Fuentes G, Shao D, Akber A, Fremeaux-Bacchi V, Sethi S, Nester CM, Smith RJH. Am J Kidney Dis; 2017 Dec; 70(6):834-843. PubMed ID: 28838767 [Abstract] [Full Text] [Related]
10. C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes. Wong EKS, Marchbank KJ, Lomax-Browne H, Pappworth IY, Denton H, Cooke K, Ward S, McLoughlin AC, Richardson G, Wilson V, Harris CL, Morgan BP, Hakobyan S, McAlinden P, Gale DP, Maxwell H, Christian M, Malcomson R, Goodship THJ, Marks SD, Pickering MC, Kavanagh D, Cook HT, Johnson SA, MPGN/DDD/C3 Glomerulopathy Rare Disease Group and National Study of MPGN/DDD/C3 Glomerulopathy Investigators. Clin J Am Soc Nephrol; 2021 Nov; 16(11):1639-1651. PubMed ID: 34551983 [Abstract] [Full Text] [Related]
12. Treatment of C3 glomerulopathy with complement blockers. Vivarelli M, Emma F. Semin Thromb Hemost; 2014 Jun; 40(4):472-7. PubMed ID: 24799307 [Abstract] [Full Text] [Related]
13. C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis. Xiao X, Pickering MC, Smith RJ. Semin Thromb Hemost; 2014 Jun; 40(4):465-71. PubMed ID: 24799308 [Abstract] [Full Text] [Related]
14. Liver factor B silencing to cure C3 glomerulopathy: Evidence from a mouse model of complement dysregulation. Zanchi C, Locatelli M, Corna D, Cerullo D, Fishilevich E, Desai D, Rottoli D, Donadelli R, Noris M, Zoja C, Remuzzi G, Benigni A. Mol Immunol; 2023 Sep; 161():25-32. PubMed ID: 37481826 [Abstract] [Full Text] [Related]
15. Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment. Noris M, Daina E, Remuzzi G. Nephrol Dial Transplant; 2023 Feb 13; 38(2):283-290. PubMed ID: 34596686 [Abstract] [Full Text] [Related]
16. Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series. Avasare RS, Canetta PA, Bomback AS, Marasa M, Caliskan Y, Ozluk Y, Li Y, Gharavi AG, Appel GB. Clin J Am Soc Nephrol; 2018 Mar 07; 13(3):406-413. PubMed ID: 29326307 [Abstract] [Full Text] [Related]
17. Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options. Bartoli G, Dello Strologo A, Grandaliano G, Pesce F. Int J Mol Sci; 2024 Jun 13; 25(12):. PubMed ID: 38928213 [Abstract] [Full Text] [Related]
18. [Diagnosis and treatment of glomerular diseases with a membranoproliferative glomerulonephritis (MPGN) pattern of injury]. Rudnicki M, Windpessl M, Eller K, Odler B, Gauckler P, Neumann I, Zitt E, Regele H, Kronbichler A, Lhotta K, Säemann MD. Wien Klin Wochenschr; 2023 Aug 13; 135(Suppl 5):688-695. PubMed ID: 37728653 [Abstract] [Full Text] [Related]
19. Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft. Moog P, Jost PJ, Büttner-Herold M. BMC Nephrol; 2018 May 03; 19(1):106. PubMed ID: 29724174 [Abstract] [Full Text] [Related]
20. Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression. Häffner K, Michelfelder S, Pohl M. Pediatr Nephrol; 2015 Nov 03; 30(11):1951-9. PubMed ID: 25986912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]